NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market on Tuesday an 11 percent increase year over year for its fourth quarter.

The San Diego-based life sciences informatics firm reported GAAP revenues of $44.2 million for the three months ended Dec. 31, 2012 compared to $39.8 million in the year-ago period, beating the average Wall Street estimate of $43.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.